Rare Diseases Report 2021

Adaptive therapy borrows from nature to keep rhabdomyosarcoma in check

Publish date: December 14, 2021

 

References

1. Reed DR et al. Cancer. 2020 Jun 1;126(11):2577-87 2. Bisogno G et al. J Clin Oncol. 2018;36:18_suppl,LBA-2

Pages

Recommended Reading

mCODE: Improving data sharing to enhance cancer care
MDedge Hematology and Oncology
Doxorubicin-pomalidomide combo shows promise for Kaposi sarcoma
MDedge Hematology and Oncology
Don’t delay: Cancer patients need both doses of COVID vaccine
MDedge Hematology and Oncology
One in three cancer articles on social media has wrong info
MDedge Hematology and Oncology
Immunotherapy for cancer patients with poor PS needs a rethink
MDedge Hematology and Oncology
Most community-based oncologists skip biomarker testing
MDedge Hematology and Oncology
Many patients, doctors unaware of advancements in cancer care
MDedge Hematology and Oncology
Genes related to osteosarcoma survival identified
MDedge Hematology and Oncology
Convenience, not outcomes may drive robot-assisted surgeries
MDedge Hematology and Oncology
Severe COVID two times higher for cancer patients
MDedge Hematology and Oncology